News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Puts Achillion Pharmaceuticals, Inc. (ACHN) Hepatitis C Drug on Clinical Hold


7/2/2013 6:03:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Achillion Pharmaceuticals Inc. (ACHN) said U.S. regulators put a hold on a clinical trial of one of the company’s experimental drugs for hepatitis C after some patients experienced elevated liver enzymes. The company’s shares declined in extended trading after the announcement.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at Market Watch
Read at RTT News
Read at Wall Street Journal

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES